Systemic sclerosis and Respiratory acidosis
Summary:
Respiratory acidosis is found among people with Systemic sclerosis, especially for people who are female, 60+ old.
The study analyzes which people have Respiratory acidosis with Systemic sclerosis. It is created by eHealthMe based on reports of 17 people who have Systemic sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Systemic sclerosis?
Systemic sclerosis (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 67 drugs and 161 conditions by eHealthMe. Check the latest studies of Systemic sclerosis.
What is Respiratory acidosis?
Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease) is found to be associated with 2,243 drugs and 3,540 conditions by eHealthMe. Check the latest studies of Respiratory acidosis.
17 people who have Systemic Sclerosis and Respiratory Acidosis are studied.

Gender of people who have Systemic Sclerosis and experienced Respiratory Acidosis *:
- female: 78.57 %
- male: 21.43 %
Age of people who have Systemic Sclerosis and experienced Respiratory Acidosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 50 %
Common co-existing conditions for these people *:
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 29.41%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 17.65%
- Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 5.88%
- Interstitial Lung Disease: 1 person, 5.88%
- Immunodeficiency Disorders: 1 person, 5.88%
- High Blood Pressure: 1 person, 5.88%
- Connective Tissue Disorder (any disease that has the connective tissues of the body): 1 person, 5.88%
Common drugs taken by these people *:
- Letairis: 6 people, 35.29%
- Gleevec: 3 people, 17.65%
- Prednisolone: 2 people, 11.76%
- Xarelto: 1 person, 5.88%
- Cyclophosphamide: 1 person, 5.88%
- Inderal: 1 person, 5.88%
- Fluconazole: 1 person, 5.88%
- Flonase: 1 person, 5.88%
- Fentanyl: 1 person, 5.88%
- Duragesic-100: 1 person, 5.88%
Common symptoms for these people *:
- Interstitial Lung Disease: 4 people, 23.53%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 23.53%
- Pneumonia: 4 people, 23.53%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 23.53%
- Pleural Effusion (water on the lungs): 3 people, 17.65%
- Pulmonary Alveolar Haemorrhage (acute bleeding): 2 people, 11.76%
- Cardiac Tamponade (fluid accumulates in heart covering): 2 people, 11.76%
- Pericardial Effusion (fluid around the heart): 2 people, 11.76%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 11.76%
- Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Respiratory acidosis?
- Check whether Respiratory acidosis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Systemic sclerosis (1,209 reports)
- Respiratory acidosis (90,650 reports)
All the drugs that are associated with Respiratory acidosis:
- Respiratory acidosis (2,243 drugs)
All the conditions that are associated with Respiratory acidosis:
- Respiratory acidosis (3,540 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Respiratory acidosis and Systemic sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rosacea and Skin Burning Sensation - 5 seconds ago
- Could Norco cause Abdominal Abscess? - 19 seconds ago
- Rashes and Pain Exacerbated - 22 seconds ago
- Could Tylenol cause Progressive Multifocal Leukoencephalopathy? - 26 seconds ago
- Drug interactions of Tranxene and Vesicare - 32 seconds ago
- Drug interactions of Azulfidine and Enbrel - 35 seconds ago
- Could Promazine Hydrochloride cause Hyperhidrosis? - 35 seconds ago
- Could Adderall cause Muscle Tightness? - 42 seconds ago
- Could Colace cause Nervous System Disorder? - 49 seconds ago
- Could Nitrostat cause Pulmonary Embolism? - 51 seconds ago